Home LiteratureArticle Details
PMID: 21666717 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Kinome siRNA-phosphoproteomic screen identifies networks regulating AKT signaling.

Oncogene ·Vol. 30 ·No. 45 ·2011-11-10 ·Pages 4567-77

Lu Y, Muller M, Smith D, Dutta B, Komurov K, Iadevaia S, Ruths D, Tseng JT, Yu S, Yu Q, Nakhleh L, Balazsi G, Donnelly J, Schurdak M, Morgan-Lappe S, Fesik S, Ram PT, Mills GB

Abstract

To identify regulators of intracellular signaling, we targeted 541 kinases and kinase-related molecules with small interfering RNAs (siRNAs), and determined their effects on signaling with a functional proteomics reverse-phase protein array (RPPA) platform assessing 42 phospho and total proteins. The kinome-wide screen demonstrated a strong inverse correlation between phosphorylation of AKT and mitogen-activated protein kinase (MAPK) with 115 genes that, when targeted by siRNAs, demonstrated opposite effects on MAPK and AKT phosphorylation. Network-based analysis identified the MAPK subnetwork of genes along with p70S6K and FRAP1 as the most prominent targets that increased phosphorylation of AKT, a key regulator of cell survival. The regulatory loops induced by the MAPK pathway are dependent on tuberous sclerosis complex 2 but demonstrate a lesser dependence on p70S6K than the previously identified FRAP1 feedback loop. The siRNA screen also revealed novel bi-directionality in the AKT and GSK3 (Glycogen synthase kinase 3) interaction, whereby genetic ablation of GSK3 significantly blocks AKT phosphorylation, an unexpected observation as GSK3 has only been predicted to be downstream of AKT. This method uncovered novel modulators of AKT phosphorylation and facilitated the mapping of regulatory loops.

MeSH Terms
Cell Line, Tumor Cell Survival/genetics Humans Metabolic Networks and Pathways/genetics,physiology Phosphoproteins/genetics,metabolism Phosphorylation Proteomics Proto-Oncogene Proteins c-akt/genetics,metabolism RNA, Small Interfering/metabolism Signal Transduction/genetics,physiology Tuberous Sclerosis Complex 2 Protein Tumor Suppressor Proteins/genetics,metabolism
Chemicals
Phosphoproteins RNA, Small Interfering Tuberous Sclerosis Complex 2 Protein Tumor Suppressor Proteins Proto-Oncogene Proteins c-akt
Authors & Affiliations
18 authors, click to expand affiliations / ORCID
Lu Y
Department of Systems Biology, UT MD Anderson Cancer Center, Houston, TX 77054, USA.
Muller M
Smith D
Dutta B
Komurov K
Iadevaia S
Ruths D
Tseng J T
Yu S
Yu Q
Nakhleh L
Balazsi G
Donnelly J
Schurdak M
Morgan-Lappe S
Fesik S
Ram P T
Mills G B
References (37)
37 references, click to expand
  1. Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737.
    Cancer Res. 2007 Feb 1;67(3):1176-83 PMID: 17283153
  2. A module of negative feedback regulators defines growth factor signaling.
    Nat Genet. 2007 Apr;39(4):503-12 PMID: 17322878
  3. Formation of regulatory patterns during signal propagation in a Mammalian cellular network.
    Science. 2005 Aug 12;309(5737):1078-83 PMID: 16099987
  4. Comprehensive mapping of the human kinome to epidermal growth factor receptor signaling.
    J Biol Chem. 2010 Jul 2;285(27):21134-42 PMID: 20421302
  5. A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.
    Cancer Cell. 2007 Oct;12(4):395-402 PMID: 17936563
  6. Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance.
    Nat Cell Biol. 2005 Jun;7(6):591-600 PMID: 15864305
  7. Survivin depletion preferentially reduces the survival of activated K-Ras-transformed cells.
    Mol Cancer Ther. 2007 Jan;6(1):269-76 PMID: 17237286
  8. Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase.
    Oncogene. 2006 Oct 16;25(48):6361-72 PMID: 17041622
  9. A new mutational AKTivation in the PI3K pathway.
    Cancer Cell. 2007 Aug;12(2):104-7 PMID: 17692802
  10. RNAi-based screening of the human kinome identifies Akt-cooperating kinases: a new approach to designing efficacious multitargeted kinase inhibitors.
    Oncogene. 2006 Mar 2;25(9):1340-8 PMID: 16247451
  11. Signaling--2000 and beyond.
    Cell. 2000 Jan 7;100(1):113-27 PMID: 10647936
  12. mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt.
    Cancer Res. 2006 Feb 1;66(3):1500-8 PMID: 16452206
  13. Molecular mechanisms underlying ErbB2/HER2 action in breast cancer.
    Oncogene. 2000 Dec 11;19(53):6102-14 PMID: 11156523
  14. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis.
    Cell. 2005 Apr 22;121(2):179-93 PMID: 15851026
  15. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism.
    Nat Rev Genet. 2006 Aug;7(8):606-19 PMID: 16847462
  16. Network topology determines dynamics of the mammalian MAPK1,2 signaling network: bifan motif regulation of C-Raf and B-Raf isoforms by FGFR and MC1R.
    FASEB J. 2008 May;22(5):1393-403 PMID: 18171696
  17. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth.
    Cell. 2006 Sep 8;126(5):955-68 PMID: 16959574
  18. Rapidly exploring structural and dynamic properties of signaling networks using PathwayOracle.
    BMC Syst Biol. 2008 Aug 19;2:76 PMID: 18713463
  19. Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways.
    Hum Mol Genet. 2005 Oct 15;14 Spec No. 2:R251-8 PMID: 16244323
  20. Use of data-biased random walks on graphs for the retrieval of context-specific networks from genomic data.
    PLoS Comput Biol. 2010 Aug 19;6(8): PMID: 20808879
  21. Exploiting the PI3K/AKT pathway for cancer drug discovery.
    Nat Rev Drug Discov. 2005 Dec;4(12):988-1004 PMID: 16341064
  22. Identification of optimal drug combinations targeting cellular networks: integrating phospho-proteomics and computational network analysis.
    Cancer Res. 2010 Sep 1;70(17):6704-14 PMID: 20643779
  23. Quantitative phosphorylation profiling of the ERK/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors.
    Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):667-72 PMID: 15647351
  24. Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2.
    Genes Dev. 2005 Aug 1;19(15):1773-8 PMID: 16027169
  25. Protein kinase C-alpha overexpression stimulates Akt activity and suppresses apoptosis induced by interleukin 3 withdrawal.
    Oncogene. 1999 Nov 11;18(47):6564-72 PMID: 10597260
  26. Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors.
    Cancer Res. 2008 Oct 15;68(20):8322-32 PMID: 18922904
  27. Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism.
    Oncogene. 2007 Mar 22;26(13):1932-40 PMID: 17001314
  28. AKT/PKB signaling: navigating downstream.
    Cell. 2007 Jun 29;129(7):1261-74 PMID: 17604717
  29. Identification of Ras-related nuclear protein, targeting protein for xenopus kinesin-like protein 2, and stearoyl-CoA desaturase 1 as promising cancer targets from an RNAi-based screen.
    Cancer Res. 2007 May 1;67(9):4390-8 PMID: 17483353
  30. Dissociation of Akt1 from its negative regulator JIP1 is mediated through the ASK1-MEK-JNK signal transduction pathway during metabolic oxidative stress: a negative feedback loop.
    J Cell Biol. 2005 Jul 4;170(1):61-72 PMID: 15998799
  31. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.
    Cancer Cell. 2006 Dec;10(6):515-27 PMID: 17157791
  32. The hallmarks of cancer.
    Cell. 2000 Jan 7;100(1):57-70 PMID: 10647931
  33. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase.
    Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13489-94 PMID: 15342917
  34. Growth inhibition and radiosensitization of glioblastoma and lung cancer cells by small interfering RNA silencing of tumor necrosis factor receptor-associated factor 2.
    Cancer Res. 2008 Sep 15;68(18):7570-8 PMID: 18794145
  35. 'Seed' analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737.
    Oncogene. 2007 Jun 7;26(27):3972-9 PMID: 17173063
  36. Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells.
    Mol Cancer Ther. 2006 Oct;5(10):2512-21 PMID: 17041095
  37. The signaling petri net-based simulator: a non-parametric strategy for characterizing the dynamics of cell-specific signaling networks.
    PLoS Comput Biol. 2008 Feb 29;4(2):e1000005 PMID: 18463702
Article Info
Journal
Oncogene
Abbr.
Oncogene
ISSN
1476-5594
Published
2011-11-10
Epub
2011-00-13
Pages
4567-77
Language
English
Region
England
NLM ID
8711562
PMCID
PMC3175328
Subset
IM
Grants
NCI NIH HHS · P30CA16672 · United States
NCI NIH HHS · R01 CA125109-03 · United States
NCI NIH HHS · P30 CA016672 · United States
NCI NIH HHS · U54 CA112970 · United States
NCI NIH HHS · P50 CA083639 · United States
NIDDK NIH HHS · T90DK070109 · United States
NCI NIH HHS · P01 CA099031 · United States
NCI NIH HHS · U54 CA112970-06 · United States
NCI NIH HHS · R01 CA125109 · United States
NIDDK NIH HHS · T90 DK070109 · United States
NCI NIH HHS · P01CA099031 · United States
PHS HHS · DPA86424-444938 · United States
NCI NIH HHS · P50CA083639 · United States
NCI NIH HHS · R01CA125109 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]